Vaccine contents


PUBLISHED: 2005 CATEGORY: TYPE: External Link Mise à jour des recommandations concernant l'utilisation de vaccins contenant du thimérosal au Canada

Mise à jour des recommandations concernant l'utilisation de vaccins contenant du thimérosal au Canada

Conclut qu’il n’y a aucune raison pour les vaccinateurs et les autres professionnels de la santé qui offrent des conseils en matière de vaccination d’exprimer des réserves concernant l’exposition au thimérosal.

Corporate Authors: Comité consultatif national de l'immunisation
Journal Issue: ACS-12
Journal Title: Relevé des maladies transmissibles au Canada
Journal Volume: 31
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2005 CATEGORY: Health care providers TYPE: External Link Updated recommendations on the use of thimerosal-containing vaccines in Canada

Updated recommendations on the use of thimerosal-containing vaccines in Canada

Concludes that there is no reason for vaccine providers or other health care professionals who may counsel individuals regarding immunization to raise any concerns regarding exposure to thimerosal.

Corporate Authors: National Advisory Committee on Immunization
Journal Issue: ACS-12
Journal Title: Canada Communicable Disease Report
Journal Volume: 31
Publisher: Public Health Agency of Canada

PUBLISHED: 2004 CATEGORY: Health care providers TYPE: External Link Thimerosal exposure in infants and developmental disorders : a prospective cohort study in the United Kingdom does not support a causal association

Thimerosal exposure in infants and developmental disorders : a prospective cohort study in the United Kingdom does not support a causal association

Describes research that tested a large United Kingdom population-based cohort to find out whether there is any evidence to justify concerns that exposure to mercury damages young children.

Authors: Andrews N et al.
Journal Issue: 3
Journal Title: Pediatrics
Journal Volume: 114
Publisher: American Academy of Pediatrics
Pubmed: 15342824

PUBLISHED: 2003 CATEGORY: Health care providers TYPE: External Link Autism and thimerosal-containing vaccines: lack of consistent evidence for an association

Autism and thimerosal-containing vaccines: lack of consistent evidence for an association

Compared the prevalence/incidence of autism in California, Sweden, and Denmark with average exposures to thimerosal-containing vaccines.

Authors: Stehr-Green P et al.
Journal Issue: 2
Journal Title: American Journal of Preventative Medicine
Journal Volume: 25
Publisher: Elsevier
Pubmed: 12880876

PUBLISHED: 2003 CATEGORY: TYPE: External Link Déclaration sur le thimérosal

Déclaration sur le thimérosal

Fournit des recommandations sur l’utilisation des vaccins homologués au Canada qui contiennent du thimérosal, un agent de conservation à base de mercure.

Corporate Authors: Comité consultatif national de l'immunisation
Journal Issue: ACS-1
Journal Title: Relevé des maladies transmissibles au Canada
Journal Volume: 29
Publisher: Agence de la santé publique du Canada
Pubmed: 12632795

PUBLISHED: 2003 CATEGORY: Health care providers TYPE: External Link Statement on thimerosal

Statement on thimerosal

Provide recommendations on the use of vaccines licensed for use in Canada that contain the mercury-based preservative thimerosal.

Corporate Authors: National Advisory Committee on Immunization
Journal Issue: ACS-1
Journal Title: Canada Communicable Disease Report
Journal Volume: 29
Publisher: Public Health Agency of Canada
Pubmed: 12632795

PUBLISHED: 2003 CATEGORY: Health care providers TYPE: External Link Thimerosal and the occurrence of autism : negative ecological evidence from Danish population-based data

Thimerosal and the occurrence of autism : negative ecological evidence from Danish population-based data

Examines whether discontinuing the use of thimerosal-containing vaccines in Denmark led to a decrease in the incidence of autism.

Authors: Plesner AM et al.
Journal Issue: 3
Journal Title: Pediatrics
Journal Volume: 112
Publisher: American Academy of Pediatrics
Pubmed: 12949291

PUBLISHED: 2002 CATEGORY: TYPE: External Link Exposition au thimérosal contenu dans les vaccins administrés dans le cadre des programmes de vaccination infantile au Canada et risques d'anomalies du développement neurologique

Exposition au thimérosal contenu dans les vaccins administrés dans le cadre des programmes de vaccination infantile au Canada et risques d'anomalies du développement neurologique

Examine le risque d’anomalies du développement neurologique, y compris l’autisme, chez les nourrissons/enfants au Canada résultant de l’exposition au mercure dans des vaccins contenant le thimérosal  dans des programmes provinciaux/territoriaux actuels de vaccination des nourrissons et des petits enfants.

Authors: Bigham M et al.
Journal Issue: 9
Journal Title: Relevé des maladies transmissibles au Canada
Journal Volume: 28
Publisher: Agence de la santé publique du Canada
Pubmed: 12012653

PUBLISHED: 2002 CATEGORY: Health care providers TYPE: External Link Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders

Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders

Examines the risk of neurodevelopmental disorders, including autism, in Canadian children as a result of mercury exposure from thimerosal-containing vaccines routinely used in some provincial/territorial universal infant and early childhood immunization programs

Authors: Bigham M et al.
Journal Issue: 9
Journal Title: Canada Communicable Disease Report
Journal Volume: 28
Publisher: Public Health Agency of Canada
Pubmed: 12012653